Indefinite Delivery Contract 75N95018D00012
Award Date
7/14/18
Last Date to Order
7/13/21
Federal Agency
National Institute on Drug Abuse
Awardee
Kelly Services, Inc.
Ultimate Awardee
Ingenesis Inc.
NAICS Category
541690 - Other Scientific and Technical Consulting Services
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institute on Drug Abuse, on behalf of the National Institute of Mental Health, awarded an indefinite delivery contract to Kelly Services, Inc. to provide scientific, technical, and professional support services. Task orders against the contract valued from $552 to $8.3M were issued to obtain services such as program support, transition support, and COVID-19 response efforts. Kelly Services will perform at the National Institutes of Health campus in Bethesda, Maryland, from July...
The National Institutes of Health National Institute on Drug Abuse awarded an indefinite-delivery/indefinite-quantity multiple award contract under the Scientific, Operations, and Administrative Resources to the National Institutes of Health vehicle. Kelly Services, Inc. was awarded numerous delivery orders against this contract vehicle valued collectively at approximately $3.6 billion over its period of performance from April 2021 through June 2026.
The delivery orders awarded to Kelly...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded an indefinite delivery/indefinite quantity (IDIQ) contract to The Emmes Company LLC, a for-profit limited liability company, to serve as the NIDA Data, Statistics, and Clinical Trial Support Center.
Under this single-award IDIQ contract valued up to $31.2 million over a five-year period from September 2022 to September 2027,...
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) with a $49,500,000 ceiling value to The Emmes Company LLC, a for-profit limited liability company, to serve as the Clinical Coordinating Center for NIDA's Clinical Trials Network (CTN). The contract has a period of performance from August 15, 2024 to August 14, 2029. Under this IDC, NIDA has issued three task orders to date,...
The National Institute on Drug Abuse, a division of the Department of Health and Human Services, awarded an Indefinite Delivery Contract to The Bizzell Group LLC to provide logistics, communications, and clinical study auxiliary support services to the Division of Therapeutics and Medical Consequences. The contract has a potential value of $1,000,000 and a period of performance from May 1, 2021 to April 30, 2026.
Under the contract, The Bizzell Group LLC has received various delivery orders...
The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, has awarded an Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, to provide synthesis and distribution services for drugs of abuse and related compounds. The contract has a ceiling value of $14,004,330 and a period of performance from June 9, 2022 to June 8, 2027. This contract supports NIDA's mission of conducting...
The National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a single-award indefinite delivery contract to The Emmes Company LLC, a global clinical research organization, to provide a range of data, statistics, and clinical trial support services in support of NIDA's mission. The contract has a potential value of $33,253,342.
Under this IDV, The Emmes Company LLC has been issued multiple task orders to provide specialized services such as data coordination, statistical...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDC) to Actuated Medical, Inc., doing business as Piezo Resonance Innovations Inc. The $35 million, single-award IDC runs through September 2028 and is for research and development services related to biocompatibility testing, animal studies, and sterilization testing in support of NIDA's Blueprint MedTech (BPMT) Initiative. This work involves...
The National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract titled "Toxicological Evaluations of Potential Medications" to Sri International, a non-profit research and development institute. The IDIQ has a ceiling value of $9,750,000 and a 5-year ordering period from September 12, 2023 through September 11, 2028. Under this IDIQ, Sri International will conduct...
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $15 million Indefinite Delivery Contract (IDC) to Rutgers, The State University to operate the NIDA Center for Genetic Studies. This single-award contract has a 5-year period of performance through March 2028.
Under this IDC, Rutgers will receive, process, store and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research...